Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Music
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/08/06/9b/08069b96-f156-f3e4-c038-a1763f179f5e/mza_3698191200806481976.jpg/600x600bb.jpg
mdtalk
mdGroup
17 episodes
4 months ago
Exploring ways we can make life better for patients taking part in clinical trials, improve access to healthcare and create better clinical outcomes, we speak to thought leaders and change makers across a range of organisations within the life sciences industry.
Show more...
Life Sciences
Health & Fitness,
Medicine,
Science
RSS
All content for mdtalk is the property of mdGroup and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Exploring ways we can make life better for patients taking part in clinical trials, improve access to healthcare and create better clinical outcomes, we speak to thought leaders and change makers across a range of organisations within the life sciences industry.
Show more...
Life Sciences
Health & Fitness,
Medicine,
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/08/06/9b/08069b96-f156-f3e4-c038-a1763f179f5e/mza_3698191200806481976.jpg/600x600bb.jpg
mdtalk | Support for parents and guardians of children with rare diseases - Episode 12
mdtalk
48 minutes 44 seconds
2 years ago
mdtalk | Support for parents and guardians of children with rare diseases - Episode 12
Episode 12 is a very special edition of mdtalk. Host LaQuinta Jernigan, Chief Operating Officer at mdgroup, is joined by Jennifer Kinnebrew, Shaniece Goodlow, and Maggie Settlemire. These incredible women have kindly agreed to join us to discuss their experiences of having children with rare diseases, and how we can advocate better care for everyone.
mdtalk
Exploring ways we can make life better for patients taking part in clinical trials, improve access to healthcare and create better clinical outcomes, we speak to thought leaders and change makers across a range of organisations within the life sciences industry.